Welcome to our dedicated page for DOCUSIGN SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DOCUSIGN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DOCUSIGN's regulatory disclosures and financial reporting.
DOCUSIGN, INC. director Anna Marrs reported mixed share activity. On March 3, 2026, she executed an open-market sale of 365 shares of common stock at $45.02 per share under a pre-arranged Rule 10b5-1 plan, leaving 11,889 shares of common stock directly owned.
On February 28, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 shares of common stock. Each RSU represents one share, with RSUs scheduled to vest quarterly starting May 29, 2025 over one year, subject to continued service, and they either vest or are canceled rather than expiring.
Anna Marrs reported an intended sale of 365 shares of common stock of DOCU as restricted stock, dated 02/28/2026, with the filing dated 03/03/2026. The filing notes prior sales of 363 shares on 12/05/2025 for $23,413.50.
DocuSign, Inc. director Teresa Briggs reported an open-market sale of common stock. On February 27, 2026, she sold 364 shares at an average price of $44.31 per share under a pre-arranged Rule 10b5-1 trading plan. Following this planned sale, she directly owns 9,170 shares of DocuSign common stock.
Teresa Briggs reported proposed sales of Common stock via a Form 144 filing. The filing lists restricted stock entries dated 05/29/2025 (340) and 02/28/2025 (24). It also records securities sold during the past 3 months showing a sale on 11/28/2025 with the entries 365 and 25254.35 as presented in the notice.
JPMorgan Chase & Co. filed a Schedule 13G reporting beneficial ownership of 13,712,039 shares of DocuSign, Inc. common stock, representing 6.4% of the outstanding class as of 12/31/2025. JPMorgan has sole power to vote and dispose of all these shares and no shared voting or dispositive power. The filing classifies JPMorgan as a parent holding company and lists several subsidiaries involved in holding the securities. JPMorgan certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of DocuSign.
DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported selling 6,500 shares of the company’s common stock on January 9, 2026 at a price of $70 per share. The filing states that the transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, indicating it was pre-arranged rather than a discretionary trade. After this sale, Grayson directly held 111,713 shares of DocuSign common stock.
DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.
A shareholder of DocuSign has filed a notice of proposed sale under Rule 144 to sell 26,250 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The filing lists an aggregate market value of $1,832,250.00 for these shares, compared with 200,272,740 shares outstanding of the same class.
The shares to be sold were acquired as restricted stock units from the issuer on 10/10/2024, in a non-cash transaction noted as “N/A” for the nature of payment. The filer represents that they are not aware of undisclosed material adverse information about DocuSign’s current or prospective operations, as required for a Rule 144 sale.
DocuSign common stockholder Blake J. Grayson has filed a Form 144 notice to sell 6,500 shares of DocuSign common stock, with an aggregate market value of $455,000. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/09/2026. The shares to be sold are common stock originally acquired as restricted stock from the issuer on 06/10/2024, in the same 6,500-share amount.
The notice also reports that during the past three months, Blake J. Grayson sold an additional 9,515 DocuSign common shares on 12/17/2025 for gross proceeds of $650,214.18. The filing states that DocuSign had 200,272,740 common shares outstanding. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about DocuSign’s current or prospective operations.